The polyisoprenylation pathway enzymes have been the focus of numerous studies to better understand the roles of polyisoprenylated proteins in eukaryotic cells and to identify novel targets against diseases such as cancer. The final step of the pathway is a reversible reaction catalyzed by isoprenyl carboxylmethyl transferase (icmt) whose products are then hydrolyzed by polyisoprenylated methylated protein methyl esterase (PMPMEase). Unlike the other pathway enzymes, the esterase has received little attention. We recently purified PMPMEase from porcine liver using an S-polyisoprenylated cysteine methyl ester substrate-dependent screening assay. However, no data is available showing its relative interaction with structurally diverse substrates. As such, its role as the putative endogenous PMPMEase has not been demonstrated. A series of substrates with S-alkyl substituents ranging from 2 to 20 carbons, including the two moieties found in polyisoprenylated proteins, were synthesized. Enzyme kinetics analysis revealed a 33-fold increase in affinity (K M values) from ethyl-(C-2, 505±63 μM), prenyl-(C-5, 294±25 μM), trans-geranyl-(C-10, 87±12 μM), trans, trans-farnesyl-(C-15, 29±2.2 μM) to all trans-geranylgeranyl-(C-20-, 15±2.7 μM) based analogs. Comparative molecular field analysis of the data yielded a cross-validated q 2 of 0.863±0.365 and a final R 2 of 0.995. Since the substrates with the S-trans, trans-farnesyl and S-all trans-geranylgeranyl moieties that occur in proteins show the highest affinity towards PMPMEase and are not hydrolyzed by the cholinesterases, the results suggest that polyisoprenylated proteins are the endogenous substrates of this esterase. The results suggest design strategies for high affinity and selective inhibitors of PMPMEase.
INTRODUCTION
Polyisoprenylation is an essential secondary modification on a wide range of proteins in eukaryotic cells [1, 2] . Their contributions to disease due to mutations or improper metabolism have been widely reported [1] . For example, an estimated 15 to 30% of cancers involve overexpression [3] or mutations of monomeric G-proteins that render them constitutively active [4] . On the other extreme of the cell viability spectrum is the degeneration observed in choroideramia caused by a defective polyisoprenylation enzyme [5, 6] . Heart-specific knockout mice devoid of the polyisoprenylated-dependent endoprotease eventually develop cardiomyopathy [7] while knockout mice lacking isoprenylated carboxylmethyltransferase (icmt, also known as prenylated protein methyl transferase, PPMTase) activity do not survive through mid gestation [8] .
While the pathophysiological effects of deficient polyisoprenyl transferase and PPMTase activities yield critical insights into the importance of the polyisoprenylation pathway, the role of the esterase that counterbalances the effects of PPMTase and makes possible the only reversible step of the pathway is less understood. Polyisoprenyl binding sites *Address correspondence to this author at the College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL 32307; USA; Tel: 850 412 7377; Lab: 850 599 8443; Fax: 850 599 3347; E-mail: nazarius.lamango@famu.edu have been identified in some proteins, thus underlying the likelihood that polyisoprenylation promotes protein-protein interactions [9, 10] . Given that PPMTase removes and PMPMEase introduces a negative charge in the vicinity of the polyisoprenyl moiety, it has been suggested that these enzymes switch the polyisoprenylated proteins between the active and inactive conformations [11] .
Although the existence of PMPMEase has been predicted from biochemical studies [12, 13] , few studies have been conducted to better understand its substrate specificity and tissue variants. PMPMEase was recently purified and identified from porcine liver [14] . It is over 70% identical and 80% similar to various ubiquitously distributed carboxylesterases [14] . The crystal structures of human carboxylesterase 1 have been solved [15] [16] [17] [18] . The data reveal an overarching feature of human carboxylesterase 1; that of a large, hydrophobic and flexible active site believed to accommodate a wide variety of substrates [15] . This may be an adaptation to accommodate the large and structurally diverse polypeptide portions bearing the hydrophobic polyisoprenylated methylated cysteines at their carboxyl terminals [14] . The present study is aimed at determining whether the enzyme is selective for polyisoprenylated methylated protein methyl esterase (PMPMEase), in which case the farnesylated and geranylgeranylated substrates would have the highest affinities for the enzyme. A series of S-alkyl,N-acyl cysteine methyl esters were thus synthesized, purified and characterized by proton and 13 C NMR and elemental analysis. Substrate kinetics analysis with the enzyme revealed a strong dependence on the polyisoprenyl moiety for high affinity binding to the esterase as shown by the significantly lower Michaelis-Menten constants for the S-trans,trans-farnesyl (C15) and S-all trans-geranylgeranyl (C20) compared to the S-ethyl cysteine methyl and other ester substrates. The requirement of polyisoprenylation for high affinity binding to PMPMEase and selectivity against cholinesterase hydrolysis is indicative of an endogenous role in the metabolism of polyisoprenylated proteins and important for the rational design of selective high-affinity inhibitors of the enzyme.
MATERIALS AND METHODS

Materials
Esterase from porcine liver (EPL), acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) were obtained from Sigma-Aldrich, St. Louis, MO. SDS-PAGE electrophoresis gels were obtained from BioRad, Hercules, CA. SDS-PAGE molecular weight markers were from Fisher Scientific (Suwanee, GA).
Synthesis of Substrates
Experiments were conducted under argon in flame-dried glassware and anhydrous solvents, when necessary (Scheme 1). Flash chromatography was performed on Fisher 40-63μ silica gel. Unless otherwise stated, NMR spectra (300 MHz) were obtained in CDCl 3 on Varian Mercury 300. Chemical shifts ( ) are given in ppm relative to the signal of the deuterated solvent. IR spectra were taken on Shimadzu 840S in KBr pellets. Optical rotations were measured on JASCO P-1020 polarimeter in a 10 cm cell. All substrates were >99% pure by HPLC. Elemental analyses were conducted by Atlantic Microlab, Inc, Norcross, GA, and the accepted values are within 0.4% of the theoretical values except otherwise noted.
trans-Geranyl bromide. A solution of PBr 3 (6 ml, 63.2 mmol) in anhydrous ether (10 mL) was added drop-wise to trans-geraniol (21.7 g, 141 mmol) in anhydrous ether (250 mL) at -15 to -10°C. At the end of the addition, the mixture was kept at 0°C for 10 min and then at 20°C for 30 min [19] . The organic phase was decanted, washed with cold 5% NaHCO 3 , brine, dried over MgSO 4 (S)-(+)-Citronellyl iodide. PPh 3 (6.3 g, 24 mmol) was added to dry DCM (80 ml) followed by imidazole (1.64 g, 24 mmol), iodine (6.1 g, 24 mmol) and a solution of (S)-(-)-citronellol (3.6 ml, 20 mmol) in dry DCM (20 ml). The mixture was stirred at RT until the alcohol disappeared (TLC in DCM, R f 0.1 alcohol, 0.9 iodide). The precipitate was filtered off, the solvent removed and the semi-solid residue was treated with hexane. The hexane extract was purified by column chromatography (in hexane) [20] 
) was added to a stirred solution of Lcysteine methyl ester hydrochloride (0.858 g, 5 mmol) in anhydrous methanol (2 mL) and 7N anhydrous NH 3 solution in methanol (4.8 mL) at -10°C. The mixture was kept for 10 min at -10°C followed by continuous stirring without cooling for 1 h. The solvent was evaporated in vacuum, the residue suspended in EtOAc, the solid filtered off and the organic phase was evaporated. The resulting residue was applied onto a column and eluted with hexane-EtOAc 1:2 followed by EtOAc. Fractions containing L-S-(S)-citronellyl)cysteine methyl ester (R f 0.25 hexane-EtOAc 1:2) were combined, shaken with p-nitrobenzoyl chloride (1.04 g, 5.4 mmol) and a solution of K 2 CO 3 (1.38 g, 10 mmol) in water (10 mL) and treated as above. Column chromatography (gradient from DCM to DCM-EtOAc 50:1) afforded 0.979 g (46% yield) of a light yellow solid, R f 0.6, hexane- 
. L-(S-ethyl)cysteine (1.49 g, 10 mmol) was reacted overnight with TMS-Cl (3 ml, 23.5 mmol) in MeOH (13 mL) at RT, giving L-(S-ethyl)cysteine methyl ester. After removal of solvent, the solid was reacted with p-nitrobenzoyl chloride (2.33 g, 12 mmol) and K 2 CO 3 (2.76 g, 20 mmol) in water -EtOAc (10+20 ml) and treated as above. Column chromatography (gradient from DCM to DCM- 
i-Amyl bromide (0.615 g, 4.1 mmol) was added to a solution of L-cysteine methyl ester (0.68 g, 3.7 mmol) in methanol (2 mL) and 7N solution of NH 3 in methanol (3.5 mL, 24.5 mmol) at -5 --10°C. The reaction mixture was stirred for 30 min at -5°C, 1h at 0°C and 1 h at RT. The solvent was evaporated in vacuum, the residue taken into EtOAc, the organic phase rotovaped and the residue purified on a column in EtOAc (1.14 g, 75%). Fractions containing L-(S-i-amyl)cysteine methyl ester (R f 0.15, hexane-EtOAc 1:1) were combined and shaken with p-nitrobenzoyl chloride (0.64 g, 3.4 mmol) and a solution of K 2 CO 3 (0.77 g, 5.6 mmol) in water (5 mL) in a separatory funnel for 5 min. After completion of the reaction (TLC in EtOAc 1:1, R f of amide 0.65) the organic phase was separated, washed with diluted NaOH, brine, dried over K 2 CO 3 . HCl (1.03 g, 6 mmol) in anhydrous MeOH (2 mL) that had been cooled to -5 o C. Prenyl chloride (0.69 g, 6.6 mmol) was then added in one portion. After 15 min at -5 o C, the mixture was put on ice for 30 min, the solvent removed in vacuum, the residue taken into EtOAc, precipitated ammonium chloride extracted with water and the organic phase vigorously shaken with p-nitrobenzoyl chloride (1.22 g, 6.6 mmol) and a solution of K 2 CO 3 (1.66 g, 12 mmol) in water (7.7 mL). After completion of the reaction, the organic phase was separated, dried over K 2 CO 3 and the solvent evaporated in vacuum. Column chromatography (gradient from DCM to DCM-EtOAc 10:7) afforded 1.44 g (68% for 2 steps) of a yellowish solid with m.p. 
N-(4-Nitrobenzoylglycyl)-S-(trans, trans-farnesyl)cysteine
methyl ester . 1N solution of N,N'-dicyclohexylcarbodiimide in DCM (1.5 mL, 1.5 mmol) was added to a stirred suspension of 4-nitrohippuric acid (336 mg, 1.5 mmol) and FarCysOMe (488 mg, 1.44 mmol) in anhydrous DCM (10 mL) and the mixture was kept at RT for one day. The solvent was evaporated in vacuum and the solid residue crystallized from hot methanol (18-1, 418 mg, 53%) ; mp 119-120°C; R f 0.4 (hexane-EtOAc). The mother liquor was evaporated in vacuum, the residue dissolved in DCM and separated on a column using a gradient DCM- 
Sequencing and Identification of Esterase from Porcine Liver
We previously reported the purification of a single esterase of about 57 kDa (SDS-PAGE) to 62 kDa (calculated) from porcine liver that hydrolyzes trans, transfarnesylated cysteine methyl ester substrates [14] . EPL obtained from Sigma-Aldrich (St. Louis, MO) was found to hydrolyze polyisoprenylated substrates while AChE and BChE did not. With limited information regarding the purity, molecular weight and amino acid sequence identity of the Sigma-Aldrich EPL, we sought to analyze it for three reasons; (1) assess its purity, (2) compare its molecular weight with the PMPMEase we previously purified from porcine liver and (3) if identical, switch to the more cost-effective commercially available enzyme. To achieve this, an aliquot of the enzyme (1 μg) was analyzed by SDS-PAGE on an 8% gel followed by EZ-Blue colloidal coomassie blue staining. The protein band was excised and submitted to ProtTech (Eagleville, PA) for trypsin digestion and LC-MS/MS sequencing and identification. An aliquot of EPL was washed on C-4 Q-tips and mixed with sinapinic acid matrix followed by analyses on the Applied Biosystems 4800 Mass Spectrometer in linear mode (Applied Biosystems, Framingham, MA).
Enzyme Assays
Each substrate (1 mM final concentration) was incubated with either PMPMEase (1-10 μg depending on substrate), acetylcholinesterase (10 μg) or butyrylcholinesterase (10 μg) in 100 mM Tris-HCl, pH 7.4 containing 5% DMSO at 37 o C (100 μl total volume). Michaelis-Menten kinetics analysis was conducted under identical conditions except with varying concentrations of the different substrates and EPL (0.1 to 5 μg/per assay depending on substrate). The reactions were stopped and analyzed as previously described [14, 24] with UV-detection at 260 nm (for the para-nitrobenzoyl susbtrates) or 214 nm for BzGFCM, HCFCM and L-69 (D-AFCM). Aliquots of the substrates were dissolved in a 50% (v/v) mixture of methanol in water containing 0.05 M NaOH and incubated at 37 o C for 1 h to hydrolyze the esters to the corresponding acid. These were then used as HPLC retention time markers as well as to generate calibration plots for data analysis. The K M and Vmax values were obtained by applying Michaelis-Menten kinetics analysis on the data using the GraphPad Prism software.
Modeling of S-Alkylated Cysteinyl-Ester Substrates
The pK M for twelve of the substrates (Table 1) were used in Comparative Molecular Field Analysis (CoMFA). The initial geometries were generated using SKETCH/Sybyl 8.0 (Tripos Associates Inc., St. Louis, MO) and the side-chains were set to the extended conformations. The Sybyl software was run under the LINUX operating system (Fedora 8.0) and the lowest energy (minimized) conformations were obtained under vacuum using the conjugate gradient method with 0.001 kcal/(mol ) gradient termination option and 5000 maximum iterations, using MMFF94s force field and MMFF94 charges.
Several alignment hypotheses were investigated in the absence of a known pharmacophore for this group of compounds. The alignment that led to the highest cross-validated (q 2 ) value was selected for the development of the final model. The minimized structure of one of the most active compounds (L-75) was used as the template. The rest of the compounds were aligned using the SYBYL "database alignment" function and a common set of 6 atoms from the ester carbonyl carbon to the first double-bond carbon of the side chain (C11-C10-C15-S16-C17-C18 shown in L-75 in Table 1 ).
RESULTS
Synthesis
The general procedures for the synthesis of the substrates are shown in Scheme 1. Proton and 13 C NMR, elemental analysis and reversed-phase high performance liquid chromatography confirmed the identities of the synthesized compounds and the over 95% purity of the compounds. 
EPL is the Same Protein as PMPMEase
SDS-PAGE analysis of EPL revealed a single major protein band of about 60.5 kDa (Fig. 1A) (Fig. 1B) . LC-MS/MS analysis of the coomassie band yielded the sequences of over twenty-five tryptic peptides which were used to identify a single protein with greater than 98% certainty. EPL was identified as EST1_PIG Liver carboxylesterase precursor, Proline-betanaphthylamidase, Retinyl ester hydrolase or carboxylesterase precursor (Sus scrofa) with a calculated molecular weight of 62621.95. EPL is thus the same protein as PMPMEase that was previously purified and identified as carboxylesterase precursor (Sus scrofa) [14] .
S-Alkylated Substrates are Hydrolyzed by PMPMEase but not AChE and BChE
When the substrates were analyzed for hydrolysis by PMPMEase, AChE and BChE, all of the substrates were significantly hydrolyzed by PMPMEase. Little or no hydrolysis was observed with AChE and BChE (Fig. 2) . The S-substitutions had a strong effect on the degree of hydrolysis by PMPMEase and the cholinesterase enzymes. The all trans-geranylgeranylated and the trans,trans-farnesylated substrates (L-69, L-70, L-75, L-76, L-80 and RD-PNB) were all very resistant to cholinesterase hydrolysis (Fig. 2) . Substrates with significantly reduced side-chains (L-74, L-102 and L-111) were more susceptible to hydrolysis by acetyl-and butyrylcholinesterases (Fig. 2) . A time-dependent study further revealed more rapid hydrolysis of the S-prenylated (L-77) and S-geranylated (L-72) substrates over the trans,trans-farnesylated and S-all trans-geranylgeranylated substrates by PMPMEase (Fig. 3) .
Michaelis-Menten Kinetics Analysis
We hypothesized that if polyisoprenylated proteins are the substrates for EPL/PMPMEase, then substrates with trans,trans-farnesyl or all trans-geranylgeranyl moieties will display the lowest K M values. The analysis revealed the typical concentration-dependent effects (Fig. 4) . As expected, the substrates with small S-substituents (e.g. ethyl and prenyl) displayed the least affinity while the trans,transfarnesyl and all trans-geranylgeranyl substrates had the highest affinities (Fig. 4) . The K M values ranged from 960 ± 180 μM (L-81, L-alanine) to 3.0 ± 0.4 μM (BzGFCM), a 320-fold increase in affinity ( Table 1) . Fig. (2) . Relative substrate hydrolysis by PMPMEase, acetyl-and butyrylcholinesterases. Each substrate was incubated with the different enzymes as described in the procedures section. These were then analyzed for the amounts of products formed. The specific activities were then computed based on the amounts of enzyme used and the duration of the incubation to determine the specific activity. The results are the means ± SEM (n=3).
Use of the D-in place of L-cysteine did not prevent hydrolysis by PMPMEase. Instead, the affinity was increased by almost 3-fold as shown by the K M values for the Lcysteine analog, RD-PNB (29 ± 2.2 μM) compared to the Dcysteine analog, L-70 (11 ± 0.9 μM). Larger O-alkyl Fig. (1) . SDS-PAGE and mass spectrometry analyses reveal EPL is the same protein as PMPMEase. (A) A 1 μg aliquot of EPL was boiled in SDS-PAGE sample buffer and subjected to electrophoresis on an 8% polyacrylamide gel followed by EZ-Blue colloidal coomassie blue staining. The molecular weight of the protein band was determined based on its migration relative to the substituents also increased the affinity towards the esterase as O-ethyl (L-76) and O-isopropyl (L-75) had lower K M values (11 ± 0.9 and 5.9 ± 0.66 μM, respectively) when compared to RD-PNB (29 ± 2.2 μM). Bond saturation on the S-substituents yielded ambiguous results as shown by the K M values for L-77 (290 ± 25 μM) versus L-81 (960 ± 180 μM) as well as L-72 (87 ± 12 μM) compared to L-83 (56 ± 9.6 μM) and L-86 (53 ± 7.0 μM). The S-benzyl analog (L-93) displayed a biphasic character in which the typical Michaelis-Menten type saturation kinetics was observed at concentrations lower than 125 μM but an inhibitory effect was observed at higher concentrations. A limited concentration range was then used to obtain the K M of 40.5 ± 3.7. Because it is difficult to determine the substrate concentration at which the inhibitory effects begin, the true K M value for L-93 may be significantly higher than the obtained value. This may have resulted in the much larger k cat /K M value for L-93 of 44,000. Table 1) .
Modeling of S-alkyl,N-acyl Cysteinyl-Ester Substrates
CoMFA is widely used to study the correlation of biological activities with the structural properties of ligands. It samples the steric and electrostatic fields around a set of ligands and correlates them to the experimental binding affinities. Evaluation of the alignment maps (Fig. (5) , top panels) shows that the spatial location of the p-nitrobenzoyl moiety in the S-isomers compared to the R-isomers ( Table 2 and a plot of the predicted against experimental binding affinities (pK M ) is shown in Fig. (6) . A predicted pK M of 4.72 was obtained for L-80 that was not included in the training set, compared to its experimental value of 4.82.
CoMFA contour maps are useful in providing visual displays of areas where the steric and electrostatic fields significantly affect binding affinities. Fig. (7) (top left panel) shows the contour map of the model with the polyisoprenyl group of the template compound, L-75, interacting with the green region of the final CoMFA fields. On the other hand, L-81, (Fig. (7) top right panel), does not extend to interact with this region. The insufficient interactions (Fig. (7) bottom left panel) are observed with other substrates with smaller Ssubstituents than L-75. The S-alkyl side chains of L-83 and L-86 have C-18-saturated carbons which result in them being placed away from the equivalent side chain of the template molecule (Fig. (7) bottom right panel), preventing them from interacting with the green contour region. The steric contour map also shows a smaller green region adjacent to the ester carbonyl carbon (C11). The contribution of the electrostatic field is low (28%) and does not provide an interpretive result.
DISCUSSION
Although a single polyisoprenylated substratemetabolizing esterase was previously purified, sequenced and identified from porcine liver [14] , its selectivity towards small molecule trans,trans-farnesylated and S-all trans-geranylgeranylated cysteine methyl esters that would be indicative of its status as the polyisoprenylation-dependent esterase has not been demonstrated. Such an esterase would have higher affinities (lower K M values) for S-trans,transfarnesylated and S-all trans-geranylgeranylated cysteine methyl esters than for other S-alkyl substituents. The significantly higher affinity of the enzyme towards the Strans,trans-farnesylated and S-all trans-geranylgeranylated cysteine methyl esters indicates that polyisoprenylated proteins are most likely the endogenous substrates of the enzyme. Since the substrates with progressively shorter Salkyl groups displayed increasingly lower affinity towards the enzyme, it can be inferred, as shown in the modeling contour maps, that the polyisoprenyl moiety is pivotal in the active site binding interactions. Studies with synthetic mimics of the carboxyl terminals of polyisoprenylated proteins revealed similar affinities towards PPMTase [25] [26] [27] [28] . The strong correlation between the experimental and predicted binding affinities affirms the principal finding that S-trans, trans-farnesylation and S-all trans-geranylgerannylation constitute high affinity elements of a substrate towards the enzyme. The low turnover rates for the S-trans,trans-farnesylated and S-all trans-geranylgeranylated cysteine methyl ester substrates compared to the short S-alkyl substrates is not unexpected. As the modeling contour maps reveal, the strong binding site is beyond the reach of short S-alkyl chains compared to the S-tran,trans-farnesyl and S-all transgeranylgeranyl moieties. The products from substrates bearing the latter two therefore interact more strongly with the enzyme resulting in slower dissociations than the short chain S-alkyls, thereby prolonging enzyme recovery times resulting in lower turnover rates. Bond saturation around C-18 as in compounds L-83 and L-86 compared to L-72 and L-81 compared to L-77 had opposing effects on the affinity towards the enzyme. This suggests that a trigonal planar structure may be preferred at this position. The tetrahedral structure arising from the saturation, though negatively impacting the affinity (L-81), resulted in a different spatial orientation of the additional isoprene in L-83 and L-86 as the modeling depicts. This might have resulted in affinity contacts for L-83 and L-86 with the enzyme molecule that more than compensates for the diminished affinity displayed in L-81. This is corroborated by the aligned structures which reveal the profiles of the S-alkyl portions of L-83 and L-86 slightly turning at a different trajectory at the saturation point from those of L-72 and the other molecules. The alignment from the susceptible carbonyl carbon through to the first two carbon atoms of the S-alkyl substituents explains why the D-cysteine analogs were surprisingly hydrolyzed by the enzyme. It appears from these that the spatial orientation of the N-substituents is the most altered while the S-alkyl groups that are important for affinity and the ester group that is the target for hydrolysis are not affected by the switch from L-to D-cysteine. The much higher k cat /K M value for the S-benzyl substrate (L-93) is most likely a result of the inhibitory effect (on the K M ) that is more obvious at high concentrations. Although the lower concentrations were used in the Michaelis-Menten kinetics computations, the inhibitory effects may have been large enough to significantly suppress the K M . The K M as shown is at least 2 to 24-fold smaller than the K M values for the comparably sized L-72, L-81 and L-77. A lesser pronounced inhibitory effect at concentrations over 200 μM was also observed for HCFCM and BzGFCM. Unlike the other substrates, the latter two compounds and L-93 are characterized by a planar unsubstituted benzene ring in the molecule which may fit into a fissure-like allosteric inhibitory site on the enzyme molecule. Fig. (6) . Predicted (y-axis) versus experimental logs of the binding affinities (pK M , X-axis). The experimental pK M for one compound was removed from the model and the model was then used to obtain the predicted pK M for that substrate. This process was repeated for the other substrates to obtain the respective pK M values. The results of the predicted pK M values were then plotted against the experimentally-derived binding affinities.
The wide distribution of PMPMEase in various organs [24] is in line with the highly ubiquitous nature of their putative polyisoprenylated proteins. Although these enzymes are yet to be characterized, various esterases with sequence identities to PMPMEase in excess of 70% have been reported from the intestines [29] , human brain [30] , human alveolar macrophages [31] , human monocytes and macrophages [31, 32] . The resistance of the substrates to hydrolysis by the cholinesterase enzymes is further testimony that the endogenous polyisoprenylated methylated proteins are indeed most likely specifically metabolized by PMPMEase. An unidentified rod outer segment hydrolase which also shows a preference for polyisoprenylated substrates has been reported [12] . The reliance on polyisoprenylation for high affinity is in agreement with previous work in which no other esterase was identified following the enzyme purification with polyisoprenylated substrate-dependent assay screening of the collected fractions [14] . Polyisoprenyl tranferases are highly specific towards the trans,trans-farnesyl and all trans-geranylgeranyl groups [33] . Likewise, the endoprotease and the methyl transferase are dependent on the polyisoprenylation for effective catalysis [26, 28, 34, 35] . The modifications probably serve a protein-protein interaction function [9] as well as recognition elements for the pathway enzymes.
Previous work in which S-adenosyl-L-methioninedependent methylation precipitated a Parkinson's diseaselike effect [36] that was abrogated by trans,trans-farnesyl-Lcysteine analogs [37, 38] indicates that aberrations in the pathway may contribute to more clinical conditions than has been reported. The current study validates the enzyme as the likely liver polyisoprenylated protein-metabolizing esterase and provides a platform for the synthesis of specific high affinity inhibitors to further explore the role of the enzyme in physiology and disease as well as lead compounds for pharmaceutical drug development.
CONCLUSION
With all other parameters constant and varying only the S-substituents, the Michaelis-Menten kinetics results demonstrate that substrates with the all trans-geranylgeranyl and trans,trans-farnesyl have the highest affinities towards PMPMEase. These are the moieties used in the secondary modification of proteins in eukaryotic cells. Furthermore, PMPMEase has the endoplasmic reticulum-retention signal that would co-localize it with PPMTase. These are strong indications that polyisoprenylated proteins are the putative endogenous substrates of the enzyme. The results further demonstrate that inhibitors synthesized with trans,transfarnesyl and all trans-geranylgeranyl groups are more likely to bind to PMPMEase with higher affinity than to such enzymes as the cholinesterases. 
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